The observed leukocyte infiltration in wild type and Ackr2-deficient mice was similar, as well as the concentrations of multiple chemokines [96], suggesting that, in this IBD model, Ackr2 does not seem to modulate chemokine bioavailability. This evidence concerns the gene ACKR2 and inflammatory bowel disease.